Usa covid-19 vaccine Usa

EXPLAINER: What's known about COVID vaccines and rare clots

Reading now: 546
www.clickorlando.com

A rare, rogue immune response is the main suspect as authorities investigate highly unusual blood clots following use of two similar COVID-19 vaccines from Johnson & Johnson and AstraZeneca.

The U.S. recommended that states pause giving the J&J vaccine on Tuesday while authorities examine six reports of the unusual clots, including a death, out of more than 6.8 million Americans given the one-dose vaccination so far.

But the small number of cases sparked concern because just last week, European authorities said similar clots were possibly linked to the AstraZeneca vaccine, which is not yet OK'd in the U.S.

That led some countries to limit its use to certain age groups. Also Tuesday, J&J delayed its imminent European rollout.

Read more on clickorlando.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA